Erschienen in:

01.12.2008 | Review

Alemtuzumab in chronic lymphocytic leukaemia, other lymphoproliferative disease and autoimmune disorders

verfasst von: M. Fiegl, G. Gastl, G. Hopfinger, K. Eigenberger, A. Zabernigg, T. Schenk, F. Falkner, A. Falkner, S. Sodia, M. Doubek, Y. Brychtova, A. Panovska, R. Greil, J. Mayer, for The Austrian Collaborative Study Group on Alemtuzumab in Chronic Lymphocytic Leukaemia, in cooperation with The Czech Leukemia Study Group for Life, CELL

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2008